Recent events

Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.

Every 8-K item filed, including the routine ones - earnings dates, shareholder votes and Regulation FD disclosures. Not the exhibit lists.

Date Company Event Filing
RF Acquisition Corp II RFAI Other event Item 8.01 Form 8-K
RadNet, Inc. RDNT Other event Item 8.01 Form 8-K
Rank One Computing Corp ROC Results announced Item 2.02 Form 8-K
Replimune Group, Inc. REPL Results announced Item 2.02 Form 8-K
Rhinebeck Bancorp, Inc. RBKB Officer or director change Item 5.02 Form 8-K
Riot Platforms, Inc. RIOT Material agreement signed Item 1.01 Form 8-K
Riot Platforms, Inc. RIOT New debt or obligation Item 2.03 Form 8-K
SES AI Corp SES Delisting notice Item 3.01 Form 8-K
SMITH MIDLAND CORP SMID Results announced Item 2.02 Form 8-K
SPACE EXPLORATION TECHNOLOGIES CORP SPCX Acquisition or disposal completed Item 2.01 Form 8-K
SPACE EXPLORATION TECHNOLOGIES CORP SPCX Unregistered share sale Item 3.02 Form 8-K
STANDEX INTERNATIONAL CORP/DE/ SXI Annual report filed FY to 2026-06-30 Form 10-K
STEEL DYNAMICS INC STLD Other event Item 8.01 Form 8-K
Sadot Group Inc. SDOT Results announced Item 2.02 Form 8-K
Safe Pro Group Inc. SPAI Results announced Item 2.02 Form 8-K
Seritage Growth Properties SRG-PA Results announced Item 2.02 Form 8-K
Sidus Space Inc. SIDU Results announced Item 2.02 Form 8-K
Silexion Therapeutics Corp SLXN Results announced Item 2.02 Form 8-K
Sinda Ltd. SIND Results announced Item 2.02 Form 8-K
SkinHealth Systems Inc. SKIN Officer or director change Item 5.02 Form 8-K
Skye Bioscience, Inc. SKYE Material agreement signed Item 1.01 Form 8-K
Skye Bioscience, Inc. SKYE Unregistered share sale Item 3.02 Form 8-K
Skye Bioscience, Inc. SKYE Shareholder rights changed Item 3.03 Form 8-K
Skye Bioscience, Inc. SKYE Change of control Item 5.01 Form 8-K
Skye Bioscience, Inc. SKYE Officer or director change Item 5.02 Form 8-K
Skye Bioscience, Inc. SKYE Charter or fiscal year changed Item 5.03 Form 8-K
Skye Bioscience, Inc. SKYE Regulation FD disclosure Item 7.01 Form 8-K
Solana Co HSDT Results announced Item 2.02 Form 8-K
Sotera Health Co SHC Officer or director change Item 5.02 Form 8-K
Sphere 3D Corp. ANY Results announced Item 2.02 Form 8-K
Sphere 3D Corp. ANY Regulation FD disclosure Item 7.01 Form 8-K
StableCoinX Inc. USDE Results announced Item 2.02 Form 8-K
Standard Nuclear, Inc. STDN Officer or director change Item 5.02 Form 8-K
Star Equity Holdings, Inc. STRR Material agreement signed Item 1.01 Form 8-K
Star Equity Holdings, Inc. STRR Results announced Item 2.02 Form 8-K
Star Equity Holdings, Inc. STRR Regulation FD disclosure Item 7.01 Form 8-K
StoneBridge Acquisition II Corp APAC Material agreement signed Item 1.01 Form 8-K
Strive, Inc. ASST Other event Item 8.01 Form 8-K
Suncrete, Inc. RMIX Results announced Item 2.02 Form 8-K
Swarmer, Inc SWMR Regulation FD disclosure Item 7.01 Form 8-K

Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.